Enantioselective distribution of albendazole metabolites in cerebrospinal fluid of patients with neurocysticercosis

British Journal of Clinical Pharmacology

Volumn 54, Issue 2, 2002, Pages 125-130

  Takayanagui, O M ^a   Bonato, P S ^a   Dreossi, S A C ^a   Lanchote, V L ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Albendazole; Cerebrospinal fluid; Cysticercosis; Enantiomers; Metabolism; Pharmacokinetics

Indexed keywords

ALBENDAZOLE; ALBENDAZOLE SULFONE; ALBENDAZOLE SULFOXIDE; DRUG METABOLITE;

ADULT; ANALYTIC METHOD; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID EXAMINATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIFFUSION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG METABOLISM; ENANTIOSELECTIVITY; FEMALE; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LUMBAR PUNCTURE; MALE; NEUROCYSTICERCOSIS; PRIORITY JOURNAL; TIME;

ADULT; ALBENDAZOLE; ANTHELMINTICS; BRAIN DISEASES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROCYSTICERCOSIS; STEREOISOMERISM;

EID: 0036037373     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.2002.01634.x     Document Type: Article

References (23)

1. Pharmacokinetics optimisation of the treatment of neurocysticercosis
2. Therapy for neurocysticercosis
3. Effect of repeated doses of albendazole on enantiomerism of its sulfoxide metabolite in goats
4. Comparative enantioselectivity in the sulphoxidation of albendazole in man, dogs and rats
5. Species differences in the generation of the chiral sulfoxide metabolite of albendazole in sheep and rats
6. Chiral behaviour of the metabolite albendazole sulphoxide in sheep, goats and cattle
7. Pharmacokinetics of albendazole in man
8. Pharmacokinetic interaction between praziquantel and albendazole in Sudanese men
9. Albendazole kinetics in patients with echinococcosis; delayed absorption and impaired elimination in cholestasis
10. Increased systemic availability of albendazole when taken with a fatty meal
11. Albendazole treatment of echinococcosis in humans: Effects on microsomal metabolism and drug tolerance
12. Dexamethasone increases plasma levels of albendazole
13. Clinical pharmacokinetics of albendazole in patients with brain cysticercosis
14. Enantioselective kinetic disposition of albendazole sulfoxide in patients with neurocysticercosis
15. Pharmacokinetic comparison of two albendazole dosage regimens in patients with neurocysticercosis
16. Therapy for neurocysticercosis. Pharmacokinetic interaction of albendazole sulfoxide with dexamethasone
17. Relative contribution of cytochromes P-450 and flavin-containing monoxygenases to the metabolism of albendazole by human liver microsomes
18. Albendazole sulfonation by rat liver cytochrome P-450c
19. Chiral sulfoxidation of albendazole by the flavin adenine dinucleotide-containing and cytochrome P450-dependent monoxygenases from rat liver microsomes
20. Simultaneous determination of albendazole sulfoxide enantiomers and albendazole sulfone in plasma
21. Medical treatment for neurocysticercosis characterized by giant subarachnoid cysts
22. The penetration of anti-infectives into the central nervous system